imatinib mesylate has been researched along with Alveolar Proteinoses, Pulmonary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, K; Hayama, N; Kojima, M; Komatsu, M; Kumaki, N; Morita, F; Ogawa, Y; Ogiya, D; Ohmachi, K; Tazume, K; Tsuboi, K | 1 |
| Feek, U; Groneberg, DA; Moll, R; Staats, P; Vogelmeier, C; Wagner, U | 1 |
2 other study(ies) available for imatinib mesylate and Alveolar Proteinoses, Pulmonary
| Article | Year |
|---|---|
Secondary pulmonary alveolar proteinosis in a patient with chronic myeloid leukemia in the accelerated phase.
Topics: Adult; Antineoplastic Agents; Benzamides; Bronchoalveolar Lavage; Fatal Outcome; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pulmonary Alveolar Proteinosis; Pyrimidines | 2008 |
Imatinib-associated pulmonary alveolar proteinosis.
Topics: Adult; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pulmonary Alveolar Proteinosis; Pyrimidines | 2003 |